Cell injection

BIOLOGICAL8 trials

Conditions

Bone CystBullous KeratopathyCorneal Endothelial DystrophyHip OsteoarthritisLiver FibrosisNonunion FracturesOsteoarthritisRelapsed/Refractory Multiple Myeloma

Early Phase 1

RD07 Cell Injection in the Treatment of Patients With Advanced Claudin18.2 Positive Solid Tumors

NCT05284968

Peking UniversitySolid Tumor

Start: 2022-04-01End: 2025-04-01Target: 36Updated: 2022-03-17

Phase 1

Treatment of Non Union of Long Bone Fractures by Autologous Mesenchymal Stem Cell

CompletedNCT01206179

Royan InstituteNonunion Fractures

Start: 2009-03-31End: 2011-05-31Updated: 2011-12-14

Treatment Of Bone Cyst With Bone Marrow Mesenchymal Cell Transplantation

CompletedNCT01207193

Royan InstituteBone Cyst

Start: 2009-10-31End: 2011-12-31Updated: 2011-12-14

Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone

CompletedNCT01454336

Royan InstituteLiver Fibrosis

Start: 2010-06-30End: 2013-07-31Updated: 2014-05-13

Autologous Chondrocyte Intra-articular Implantation in Patients With Severe Hip Osteoarthritis

CompletedNCT01500811

Royan InstituteHip Osteoarthritis

Start: 2011-03-31End: 2013-08-31Updated: 2014-04-28

Simple Non-cultured Endothelial Cell Therapy for Corneal Endothelial Dysfunction

RecruitingNCT07711561

Singapore Eye Research InstituteBullous Keratopathy, Corneal Endothelial Dystrophy

Start: 2026-06-22End: 2029-07-01Target: 20Updated: 2026-07-17

Unknown Phase

Use of Autologous Adipose-Derived Stromal Vascular Fraction To Treat Osteoarthritis of Hip, Knee, Ankle, and Thumb Joints

NCT03166410

Texas Plastic SurgeryOsteoarthritis

Start: 2017-01-31End: 2021-07-31Target: 500Updated: 2020-03-13

LCAR-M61SQ in Treatment of Relapsed/Refractory Multiple Myeloma

Not yet recruitingNCT06888752

First Affiliated Hospital of Wenzhou Medical UniversityRelapsed/Refractory Multiple Myeloma

Start: 2025-03-20End: 2030-12-30Target: 35Updated: 2025-03-21

Related Papers

Percutaneous Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Implantation Is Safe for Reconstruction of Human Lower Limb Long Bone Atrophic Nonunion.

PubMed2017-01-0128 citations

Mesenchymal Stromal Cells Implantation in Combination with Platelet Lysate Product Is Safe for Reconstruction of Human Long Bone Nonunion.